Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

NCT05793619 is registered in ClinicalTrials.gov with Cryonove Pharma as lead sponsor.

NCT NCT05793619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05793619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots
Lead sponsor
Cryonove Pharma
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2023
Completion date
October 26, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lentigo solar, senile lentigo